FDA approves Rasonque 6.5 months early, raising UAE pancreatic cancer access questions
Rasonque nearly doubled median survival in a 500-patient trial. UAE oncology teams now face testing, import and insurer approval questions.
30 Aug 2026 · 3 min read
